Literature DB >> 34288380

Tranexamic acid-loaded hemostatic nanoclay microsphere frameworks.

Isabelle Denry1,2,3, Jean-Marie Nédélec3, Julie A Holloway2.   

Abstract

Fast acting topical hemostatic agents play a key role in hemorrhage control. Retarding fibrinolysis is also critical in improving coagulation, thereby expanding chances of survival. The purpose of the present work was to investigate the physical properties, loading capacity and hemostatic efficacy of newly developed nanoclay microsphere frameworks (NMFs) loaded with tranexamic acid (TA), as antifibrinolytic agent. Nanoclay compositions were prepared with increasing levels of TA. Results showed that TA was successfully incorporated into the nanoclay structure and released when solvated with ethanol. Both doped and undoped NMFs significantly decreased activated partial thromboplastin time and increased clot stiffness, which was attributed to significantly thinner fibrin fibers and a denser clot structure.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  clotting time; hemostasis; nanoclay; topical hemostatic agent; tranexamic acid

Mesh:

Substances:

Year:  2021        PMID: 34288380      PMCID: PMC8678343          DOI: 10.1002/jbm.b.34918

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  23 in total

Review 1.  Topical hemostatic agents in surgical practice.

Authors:  Masci Emilia; Santoleri Luca; Belloni Francesca; Bottero Luca; Stefanini Paolo; Faillace Giuseppe; Bertani Gianbattista; Montinaro Carmela; Mancini Luigi; Longoni Mauro
Journal:  Transfus Apher Sci       Date:  2011-10-29       Impact factor: 1.764

2.  Physically crosslinked nanocomposites from silicate-crosslinked PEO: mechanical properties and osteogenic differentiation of human mesenchymal stem cells.

Authors:  Akhilesh K Gaharwar; Vipuil Kishore; Christian Rivera; Whitney Bullock; Chia-Jung Wu; Ozan Akkus; Gudrun Schmidt
Journal:  Macromol Biosci       Date:  2012-04-19       Impact factor: 4.979

3.  Tranexamic acid is an active site inhibitor of urokinase plasminogen activator.

Authors:  Guojie Wu; Blake A Mazzitelli; Adam J Quek; Matthew J Veldman; Paul J Conroy; Tom T Caradoc-Davies; Lisa M Ooms; Kellie L Tuck; Jonathan G Schoenecker; James C Whisstock; Ruby H P Law
Journal:  Blood Adv       Date:  2019-03-12

4.  The effects of QuikClot Combat Gauze and movement on hemorrhage control in a porcine model.

Authors:  Brian Gegel; James Burgert; John Gasko; Christian Campbell; Mark Martens; Joseph Keck; Harmony Reynolds; Michael Loughren; Don Johnson
Journal:  Mil Med       Date:  2012-12       Impact factor: 1.437

5.  pH sensitive dexamethasone encapsulated laponite nanoplatelets: Release mechanism and cytotoxicity.

Authors:  M Roozbahani; M Kharaziha; R Emadi
Journal:  Int J Pharm       Date:  2017-01-03       Impact factor: 5.875

Review 6.  Clinical pharmacology of tranexamic acid.

Authors:  B Astedt
Journal:  Scand J Gastroenterol Suppl       Date:  1987

7.  A Fibrin Cross-linking Polymer Enhances Clot Formation Similar to Factor Concentrates and Tranexamic Acid in an in vitro Model of Coagulopathy.

Authors:  Leslie W Chan; Nathan J White; Suzie H Pun
Journal:  ACS Biomater Sci Eng       Date:  2016-01-28

8.  Adsorption of tranexamic acid on hydroxyapatite: Toward the development of biomaterials with local hemostatic activity.

Authors:  Stéphanie Sarda; Farid Errassifi; Olivier Marsan; Anne Geffre; Catherine Trumel; Christophe Drouet
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2016-04-14       Impact factor: 7.328

9.  Prehospital use of hemostatic dressings in emergency medical services in the Netherlands: A prospective study of 66 cases.

Authors:  Ruben Te Grotenhuis; Pierre M van Grunsven; Wim M J M Heutz; Edward C T H Tan
Journal:  Injury       Date:  2016-01-19       Impact factor: 2.586

10.  A copper(II) paddle-wheel structure of tranexamic acid: di-chloro-tetra-kis-[μ-4-(ammonio-meth-yl)cyclo-hexane-1-carboxyl-ato-O,O']dicopper(II) dichloride hexa-hydrate.

Authors:  Muhammad Altaf; Helen Stoeckli-Evans
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2017-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.